null
null
OncologyStat
®
One Source, Many Resources.
®
By Elsevier
MULTIPLE MYELOMA
Refine Results:
All Categories
Epidemiology and Etiology (115)
Prevention and Screening (37)
Diagnosis and Staging (108)
Treatment (329)
Supportive Oncology (45)
CME
Addressing the Risk of TLS in Adult Patients: Case Studies for the Practicing Physician
An interactive CME program provided by Med-IQ
William Bensinger, MD (Consultservice 1): Practical Aspects of HSCT for Hematologic Malignancies
An interactive CME program powered by Real CME
News
Less May Be More in Treating High-Risk Myeloma
Elsevier Global Medical News, 2012 Jan 23, P Wendling
Vorinostat Delivers Mixed Results in Multiple Myeloma
Elsevier Global Medical News, 2012 Jan 17, P Wendling
Phase II Results Continue to Support Carfilzomib in Myeloma
Elsevier Global Medical News, 2012 Jan 17, P Wendling
Pomalidomide Elicits Responses When Other Myeloma Regimens Fail
Elsevier Global Medical News, 2012 Jan 11, P Wendling
Evidence Mounts for Early Treatment of Smoldering Myeloma
Elsevier Global Medical News, 2012 Jan 4, P Wendling
More News ›
Journal Scans: Research
Trisomies in Multiple Myeloma: Impact on Survival In Patients With High-Risk Cytogenetics
Blood, 2012 Jan 10, S Kumar, et al
Administration of Bortezomib Before and After Autologous Stem-Cell Transplantation Improves Outcome in Multiple Myeloma Patients With Deletion 17p
Blood, 2011 Dec 8, K Neben, et al
EXPERT COMMENTARY
High-Dose Melphalan and Peripheral Blood Stem Cell Transplantation for Light-Chain Amyloidosis With Cardiac Involvement
Blood, 2011 Dec 6, S Madan, et al
Immunoglobulin D Amyloidosis: A Distinct Entity
Blood, 2011 Nov 7, MA Gertz, et al
Risk of Acute Myeloid Leukemia and Myelodysplastic Syndromes After Multiple Myeloma and Its Precursor Disease (MGUS)
Blood, 2011 Oct 13, S Mailankody, et al
More Journal Scans: Research ›
Journal Scans: Review
Radiopharmaceuticals: When and How to Use Them to Treat Metastatic Bone Pain
J Support Oncol, 2011 Nov 1, FM Paes, et al
Treatment of Hematological Malignancies With Nonmyeloablative, HLA-Haploidentical Bone Marrow Transplantation and High Dose, Post-Transplantation Cyclophosphamide
Best Pract Res Clin Haematol, 2011 Sept 1, AT Munchel, et al
Approach to the Treatment of Multiple Myeloma: A Clash of Philosophies
Blood, 2011 Jul 25, SV Rajkumar, et al
Practical Management of Adverse Events in Multiple Myeloma: Can Therapy Be Attenuated in Older Patients?
Blood Rev, 2011 Jul 1, A Palumbo, et al
Underreporting of Neutropenic Toxicity Associated With Current Treatment Regimens for Selected Hematologic Malignancies
Community Oncology, 2011 Jul 1, SA Gregory, et al
More Journal Scans: Review ›
Expert Opinion
Dr. David Henry: It Just Keeps Getting Better and Better in Myeloma
Interview by L Scott Zoeller, 2012 Jan 25, David Henry, et al
Is There a Future for Auto-Allo HSCT in Multiple Myeloma?
Lancet Oncol, 2011 Sept 30, A Dispenzieri
Zoledronic Acid for All Patients With Newly Diagnosed Multiple Myeloma?
Lancet Oncol, 2011 Aug 1, E Terpos, et al
Subcutaneous Bortezomib: A Step Towards Optimised Drug Use
Lancet Oncol, 2011 Apr 19, M-V Mateos
Is Myeloma Curable? Where Does Auto Transplant Fit in the Wake of Novel Therapies? Interview With Dr. Sundar Jagannath
OncologySTAT Editorial Team, 2010 Dec 2, Interview by L Scott Zoeller
More Expert Opinion ›
Chemotherapy Regimens
VAD (vincristine, doxorubicin [Adriamycin], dexamethasone) (Multiple myeloma)
The Elsevier Guide to Oncology Drugs & Regimens (2008 edition)
Thalidomide, dexamethasone (Multiple myeloma)
The Elsevier Guide to Oncology Drugs & Regimens (2008 edition)
Thalidomide (Multiple myeloma)
The Elsevier Guide to Oncology Drugs & Regimens (2008 edition)
Bortezomib (Multiple myeloma)
The Elsevier Guide to Oncology Drugs & Regimens (2008 edition)
Melphalan, prednisone, thalidomide (MPT) (Multiple myeloma)
The Elsevier Guide to Oncology Drugs & Regimens (2008 edition)
More Chemotherapy Regimens ›
Conference Coverage
2011 ASH Annual Meeting and Exposition
Dec 10-13 2011 San Diego, et al
16th Congress of EHA
June 9-12 2011 London
Videos
Modified VISTA in Myeloma
Elsevier Global Medical News, 2009 Dec 7, JS MacNeil
Summary of Key Points
Multiple Myeloma and Related Disorders
Abeloff's Clinical Oncology, 4th ed. 2008
Comment
Print page
Share page
RSS feeds
Updated Key Points: Multiple Myeloma
Summary information about multiple myeloma cancer has been completely revised with updated information from Abeloff's Clinical Oncology, 4th ed.
Read more ›
ASCO
Read through news articles of studies from this year's conference.
Read more ›
Categories
News
Journal Scans
Expert Opinion
Drugs and Regimens
Conferences
CME
Videos
Supportive Care
Skeletal-Related Events
Complications, GI and Oral
Hematologic Support
Infectious Complications
Neurologic Complications
Pain
Vascular Complications
Cancer Type
Bladder
Bone
Breast
Breast (ER-Positive)
CNS/Brain
Colon and Rectum
Endocrine System
Esophagus
GYN (Non-Ovary)
GYN (Ovary)
Head and Neck
Hodgkin's Lymphoma
Kidney (Renal Cell)
Leukemia
Liver and Bile Duct
Lung
Multiple Myeloma
Myelodysplastic Syndrome
Myeloproliferative Diseases
Non-Hodgkin's Lymphoma
Pancreas
Pediatric Cancers
Prostate
Rare Cancers
Skin
Soft-Tissue Sarcoma
Stomach
Testicle
MultipleMyeloma/
anonymous
none
none
none
n
Advanced Search
Email Address
Password
Remember Me
Forgot your password?
Not a member?
Free registration
Elsevier
Home
Site Map
Cancer Types
About OncologySTAT
Privacy Policy
Terms of Use
Contact Us
Advertise
Copyright © 2012
Elsevier Inc.
All rights reserved.